Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(05): E672-E677
DOI: 10.1055/a-0849-9334
Case report
Owner and Copyright © Georg Thieme Verlag KG 2019

Endoscopic deployment of multiple (≥ 3) metal stents for unresectable malignant hilar biliary strictures

Authors

  • Tatsuya Koshitani

    1   Department of Gastroenterology, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan
  • Shuji Nakagawa

    1   Department of Gastroenterology, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan
    2   Nakagawa Naika Clinic, Kobe, Japan
  • Yoshitomo Konaka

    1   Department of Gastroenterology, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan
  • Keimei Nakano

    1   Department of Gastroenterology, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan
  • Shuichi Fuki

    1   Department of Gastroenterology, Japan Community Health Care Organization Kobe Central Hospital, Kobe, Japan
  • Yoshito Itoh

    3   Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
Further Information

Publication History

submitted 16 August 2018

accepted after revision 03 December 2018

Publication Date:
03 May 2019 (online)

Preview

Abstract

Background and study aims Endoscopic deployment of multiple (≥ 3) self-expandable metal stents (SEMS) for high-grade unresectable malignant hilar biliary strictures (UMHBS) is technically challenging. Eleven consecutive patients with high-grade UMHBS (mean age: 76 years, male/female: 5/6, Bismuth-Corlette classification IIIa/IV: 7/4) underwent endoscopic deployment of multiple SEMS using a combination of side-by-side (SBS) and stent-in-stent (SIS) methods. Technical and clinical success rates were 11/11. More than three SEMS were successfully deployed, and obstructive jaundice was fully improved in all cases. Stent occlusion was recognized in four of 11 patients (mean: 134 days, range: 28 – 232). Reinterventions for both liver lobes were feasible by passing the guide wire inside the previously placed stents in three of four patients. Median stent patency was 150 days during a mean follow-up period of 184 days (range: 37 – 558). Three patients developed self-limiting cholangitis without definite stent occlusion as late (> 30 days) adverse events. Employing the combination of SBS and SIS methods may facilitate endoscopic deployment of multiple SEMS to treat high-grade UMHBS.